TenderlineUK
Procurement Intelligence
Official OCDS
Find a Tender
complete
Official procurement procedure

The Supply and Delivery of Negative Controls

Laboratory
optical and precision equipments (excl. glasses)
Medical equipments
+1 more
Published value
Not published
Submission deadline Not published
Lots published1
Procurement Executive Summary
AI & Search Synopsis
Generated from official OCDS record
Tenderline Synopsis: Medicines Discovery Catapult: "The Supply and Delivery of Negative Controls". Published status: complete. Published value: Value not published. 1 published lot. Submission deadline not published. See the official notice for participation instructions.
Contracting AuthorityMedicines Discovery CatapultScope & CategoriesNot publishedSubmission Window
complete
No deadline published
Submission GatewayDirect notice routeLegal Basis & RegimeStandard procurementEstimated Value (exc. VAT)Not published
Bidder Intelligence · Authority Profile: Medicines Discovery Catapult
Market Analytics
View Authority Profile →
Derived from OCDS awards & bid statistics
Published history for Medicines Discovery Catapult. These figures describe retained records, not a forecast of bids or a measure of buyer bias.
Published-to-award variance
Not availableInsufficient comparable data
Requires at least 5 comparable procedures
Competition Density
1.3Bids / Report
66.7% of reports have one bid
Supplier ConcentrationNo estimate
Insufficient attributable awardsNo concentration estimate available
Payment Terms
Check noticePublished terms
Payment obligations depend on the applicable regime and contract. Consult the official documents.
Coverage: 4 active published awards; 3 bid reports (which may be per lot). Supplier values exclude multi-supplier awards, frameworks and DPS, and use GBP only. They are published award values, not payments. Published-to-award variance compares single-lot, single-award, single-supplier GBP procedures with explicitly non-framework/non-DPS status; increases remain in the average. Unpublished data stays unknown. Awarded suppliers are winners, not all bidders.
Procedure terms
Contracting AuthorityMedicines Discovery Catapult
Procedure methodNot published
Procurement categoryNot published
Statuscomplete
Framework / DPSNot published
CompetitionNot published
Above thresholdNot published
Legal basisNot published
Tender period startsNot published
Clarification deadlineNot published
Electronic submissionNot published
Submission languagesNot published
Published26 Oct 2021, 14:50 BST
Last source update26 Oct 2021, 14:50 BST
Recurring procurementNot published
ClassificationLaboratory, optical and precision equipments (excl. glasses), Medical equipments, pharmaceuticals and personal care products
Delivery area
OCIDocds-h6vhtk-02f00f
What is being bought
The supply and delivery of negative controls for the Lighthouse Laboratory required for PCR testing of COVID-19.
What changed
From the official release history
  1. Status changed to complete
    26 Oct 2021, 14:50 BST
  2. Official notice release published
    26 Oct 2021, 14:50 BST
  3. Buyer information updated
    26 Oct 2021, 14:50 BST
Lots and requirements (1)
Published by the contracting authority
  • Lot 1 · #1
    Individual lot title not published
    cancelled
    Published valueNot published
    The supply and delivery of negative controls for Covid-19 PCR testing within the Lighthouse Laboratory. Contract period until end December 2021.
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
Timeline
  1. Procedure published
    26 Oct 2021, 14:50 BST
  2. Award active
    Not published · Not published
  3. Contract active
    Signed 29 Sept 2021, 00:00 BST · £200,000
Commercial outcome and competition
Awards
Qnostics
Not published · Not published · active
Contracts
Contract
£200,000 · signed 29 Sept 2021, 00:00 BST · active
Bid statistics
bids: 1 (lot 1)
Buyer and organisations in this procedure

Medicines Discovery Catapult

Contracting authority GB-FTS-23690
View buyer profile
  • Medicines Discovery Catapult
    buyer

    Block 35, Mereside, Alderley Park, Cheshire, UKD62, SK10 4ZF
    +44 1625708394
  • Medicines Discovery Catapult
    reviewBody

    Alderley Edge
  • Qnostics
    supplier

    Glasgow, UKD62
Documents (0)
Official links; attachments are not copied
No data
No linked documents are published
Related procedures (0)
No data
No related procedures published
Planning and rationale
Planning budgetNot published
No-engagement rationaleNot published
Procedure rationaleThe positive control used is a harvest of cells producing the Virus. Therefore, the most relevant negative control is a harvest of the same cells, grown by the same supplier, in the same conditions, except not producing the virus. Thus, we cannot manufacture or obtain a more relevant control from other suppliers and competition is absent for technical reasons. These controls are now a part of the UKAS accredited workflow and so are an essential part of the process thus competition is absent for technical reasons.